A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy Failed

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

November 30, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

September 30, 2018

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG

Volasertib

Trial Locations (1)

Boehringer Ingelheim Investigational Site, Ghent